Double maintains 2 strategies that include SRRK - Scholar Rock Holding Corp.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CNYA | 28.94% | $221.60M | 0.6% |
ASHR | 26.43% | $1.95B | 0.65% |
LIT | 23.79% | $872.83M | 0.75% |
REMX | 22.60% | $287.63M | 0.56% |
GXC | 20.15% | $429.92M | 0.59% |
CQQQ | 19.01% | $999.82M | 0.65% |
KBA | 18.43% | $175.04M | 0.56% |
FLCH | 17.80% | $176.05M | 0.19% |
MCHI | 17.07% | $5.92B | 0.59% |
CXSE | 17.00% | $419.71M | 0.32% |
USL | 16.54% | $40.86M | 0.85% |
EWX | 16.24% | $667.86M | 0.65% |
BNO | 15.32% | $83.96M | 1% |
BATT | 15.24% | $57.18M | 0.59% |
DBE | 15.19% | $47.45M | 0.77% |
CHIQ | 15.19% | $243.70M | 0.65% |
OILK | 14.82% | $61.84M | 0.69% |
DBO | 14.71% | $177.14M | 0.77% |
USO | 14.20% | $957.61M | 0.6% |
JPEM | 13.78% | $332.70M | 0.44% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INNV | -<0.01% | $553.55M | +2.50% | 0.00% |
IREN | <0.01% | $1.78B | +53.27% | 0.00% |
MFA | <0.01% | $982.39M | -12.84% | 14.67% |
AAMI | -0.01% | $1.09B | +33.11% | 0.13% |
FYBR | 0.01% | $9.14B | +36.71% | 0.00% |
RNG | -0.01% | $2.51B | -26.58% | 0.00% |
SMPL | -0.01% | $3.57B | -4.76% | 0.00% |
STVN | -0.01% | $6.47B | +15.59% | 0.24% |
SBH | 0.01% | $933.27M | -15.37% | 0.00% |
GNW | 0.01% | $2.87B | +6.29% | 0.00% |
SSL | -0.02% | $2.40B | -48.09% | 0.00% |
TH | 0.02% | $683.79M | -40.70% | 0.00% |
XGN | 0.02% | $127.20M | +204.71% | 0.00% |
CEG | -0.02% | $90.31B | +29.04% | 0.51% |
PLTK | 0.02% | $1.86B | -44.59% | 8.13% |
BYND | 0.03% | $188.88M | -67.84% | 0.00% |
NKE | 0.03% | $91.11B | -32.66% | 2.54% |
PLYM | 0.03% | $736.97M | -23.32% | 5.94% |
UTI | 0.03% | $1.80B | +114.66% | 0.00% |
GLW | 0.03% | $40.26B | +33.89% | 2.38% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UVE | -48.42% | $723.60M | +26.94% | 2.48% |
HCI | -42.03% | $1.88B | +59.18% | 0.98% |
ACIC | -30.62% | $532.37M | -8.52% | 0.00% |
RNR | -29.48% | $11.65B | +7.49% | 0.65% |
HRTG | -29.31% | $730.20M | +161.49% | 0.00% |
EG | -28.32% | $14.50B | -9.09% | 2.34% |
ACGL | -20.99% | $34.05B | -2.38% | 0.00% |
CON | -20.69% | $2.74B | -9.06% | 0.29% |
CB | -19.93% | $112.76B | +11.23% | 1.28% |
IMRN | -19.86% | $11.10M | -17.75% | 0.00% |
RLI | -19.66% | $6.76B | +3.85% | 1.38% |
AIZ | -18.26% | $9.95B | +11.87% | 1.54% |
ALL | -17.24% | $53.12B | +20.64% | 1.87% |
DUK | -17.00% | $87.41B | +8.81% | 3.66% |
PLMR | -15.87% | $4.17B | +86.37% | 0.00% |
AWK | -15.86% | $26.10B | +0.05% | 2.31% |
PGR | -14.59% | $163.07B | +32.94% | 1.76% |
IAG | -14.50% | $3.52B | +36.61% | 0.00% |
KNSL | -14.41% | $10.23B | +14.74% | 0.14% |
HMN | -14.19% | $1.69B | +18.08% | 3.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OCFT | 44.80% | $243.21M | +207.44% | 0.00% |
APD | 37.42% | $60.42B | +7.90% | 2.62% |
EH | 31.30% | $1.04B | +11.13% | 0.00% |
AVNW | 31.21% | $264.64M | -33.17% | 0.00% |
NIU | 27.41% | $246.57M | +52.59% | 0.00% |
GNRC | 26.68% | $7.59B | -11.43% | 0.00% |
LQDA | 22.30% | $1.59B | +51.75% | 0.00% |
PLL | 21.90% | $150.55M | -53.37% | 0.00% |
STG | 21.89% | $26.71M | -39.86% | 0.00% |
OC | 21.89% | $12.09B | -20.82% | 1.82% |
BHVN | 21.74% | $2.01B | -46.98% | 0.00% |
CRNC | 21.69% | $413.98M | +97.32% | 0.00% |
HUSA | 20.14% | $10.59M | -51.78% | 0.00% |
CPSH | 19.68% | $26.00M | +4.68% | 0.00% |
NECB | 19.36% | $335.16M | +39.49% | 2.52% |
LSTR | 18.42% | $4.98B | -22.09% | 0.77% |
SMCI | 18.21% | $26.86B | -52.75% | 0.00% |
NOAH | 17.50% | $653.89M | -25.41% | 10.94% |
CPNG | 17.13% | $48.86B | +19.49% | 0.00% |
AIXI | 17.04% | $29.45M | -62.28% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DMXF | 0.01% | $789.14M | 0.12% |
IAGG | 0.02% | $7.27B | 0.07% |
BBJP | 0.02% | $12.72B | 0.19% |
JMUB | 0.03% | $2.78B | 0.18% |
FXO | 0.03% | $2.10B | 0.62% |
EMLP | -0.04% | $3.15B | 0.96% |
TFLO | -0.05% | $7.09B | 0.15% |
IYC | 0.06% | $1.42B | 0.39% |
PREF | 0.06% | $1.17B | 0.55% |
DFGR | 0.06% | $2.41B | 0.22% |
SCYB | 0.07% | $1.06B | 0.03% |
CLIP | 0.08% | $1.51B | 0.07% |
XPH | -0.08% | $139.13M | 0.35% |
MAGS | -0.10% | $2.13B | 0.29% |
SPHQ | 0.10% | $13.10B | 0.15% |
KCCA | 0.10% | $97.87M | 0.87% |
HYG | -0.11% | $14.80B | 0.49% |
MUB | -0.12% | $38.63B | 0.05% |
ARGT | -0.12% | $1.14B | 0.59% |
FXH | -0.13% | $903.50M | 0.62% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -16.03% | $31.21M | 0.65% |
LMBS | -15.54% | $4.96B | 0.64% |
IAK | -13.91% | $784.49M | 0.39% |
BTAL | -12.64% | $367.96M | 1.43% |
KIE | -12.07% | $947.37M | 0.35% |
CGSD | -11.33% | $1.19B | 0.25% |
BILS | -10.66% | $3.97B | 0.1356% |
SHV | -10.53% | $20.99B | 0.15% |
KMLM | -10.52% | $188.70M | 0.9% |
GBIL | -10.38% | $6.17B | 0.12% |
ICSH | -9.92% | $6.10B | 0.08% |
FPEI | -9.81% | $1.55B | 0.85% |
CARY | -9.29% | $347.36M | 0.8% |
SMIN | -9.11% | $823.72M | 0.75% |
TBLL | -9.10% | $2.46B | 0.08% |
GSY | -8.93% | $2.80B | 0.22% |
EPI | -8.82% | $3.18B | 0.85% |
XLU | -8.80% | $18.48B | 0.09% |
FTSD | -8.60% | $212.45M | 0.25% |
VPU | -8.49% | $6.76B | 0.09% |
Yahoo
Scholar Rock Holding Corp (SRRK) reports significant advancements in SMA treatment and prepares for a potential US commercial launch amid financial stability and strategic global expansion.
Yahoo
Q1 2025 Scholar Rock Holding Corp Earnings Call
SeekingAlpha
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2025 Earnings Conference Call May 14, 2025 8:15 AM ETCompany ParticipantsRushmie Nofsinger - VP, Corporate...
Yahoo
CAMBRIDGE, Mass., May 14, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today reported financial results and updates for the first quarter ended March 31, 2025.
Finnhub
Scholar Rock Holding Corp: * SCHOLAR ROCK Q1 INCOME FROM OPERATIONS USD -77.09 MILLION * SCHOLAR ROCK Q1 OPERATING EXPENSES USD 77.09 MILLION * SCHOLAR ROCK...
Finnhub
Scholar Rock Holding Corporation reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported net loss was USD 74.72 million compared to USD 56.85...
Current Value
$30.561 Year Return
Current Value
$30.561 Year Return